Bayer to acquire Perfuse Therapeutics in USD2.45bn deal to expand ophthalmology pipeline

ZYUS Life Sciences receives second US pain management patent

Citius Oncology to accelerate LYMPHIR commercialisation with up to USD36.5m in debt and equity capital

Lunai Bioworks completes USD20m preferred issuance to acquire CNS delivery and neurotherapeutic IP

Photocure study supports cost-effectiveness of blue light cystoscopy

Apotex receives Health Canada approval for a generic Ozempic equivalent

Spinogenix to present tazbentetol preclinical results in glaucoma and diabetic retinopathy models at ARVO 2026

Specialised Therapeutics' chronic graft-versus-host disease therapy approved in Australia

Telix Pharmaceuticals' MAA for TLX101-Px (Pixlumi) accepted for European review

FDB introduces gravimetric content to improve IV medication compounding

Curocell secures full approval for RIMQARTO to enter CAR-T therapy market

European Commission clears first pertuzumab biosimilar in Europe

Cirius Therapeutics introduces gestational diabetes initiative

Insilico's Rentosertib inhalation solution receives IND clearance to enter direct-to-lung clinical study

C-Ray Therapeutics' Copper-64 (Cu-64) Type II DMF gains FDA acceptance